STAT

3 global health challenges to watch in 2019

Will a new disease emerge in 2019? Will the U.S. get a licensed dengue vaccine? How do you solve a problem like Ebola?

As 2019 begins, STAT reporters are taking a look at the stories they’re most eager to track during the year. Find all of our “three to watch” series here. 

A couple years ago, the Zika virus startled the world with its until-then unrecognized ability to maim fetuses. A few years before that a camel virus — MERS — began infecting and killing people on the Arabian Peninsula. And a few years before that, H1N1 ignited the first flu pandemic in 41 years.

Does it kind of feel like we due for a new disease misadventure? Does Mother Nature have malign plans for 2019?

We have plenty of skills at STAT, but predicting the unpredictable is still out of our grasp. Know this, though: If some big new disease breaks out, we’ll be on top of it.

In the meantime,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks